GO:0045006 DNA deamination: Immune Defense and Mutagenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045006 DNA deamination is the enzymatic removal of an amino group from a DNA nucleotide base, converting cytosine to uracil.
• The process is central to adaptive immunity through somatic hypermutation and class-switch recombination, and to innate antiviral defense.
• AID (activation-induced cytidine deaminase) and APOBEC family enzymes are the principal DNA deaminases in humans.
• DNA deamination can be mutagenic and is implicated in cancers such as hepatocellular carcinoma driven by APOBEC3A.
• Spontaneous deamination of cytosine to uracil occurs preferentially on the non-transcribed DNA strand in yeast.
• Modern single-molecule sequencing can reveal DNA mismatch and damage patterns arising from deamination.
Description
DNA deamination (GO:0045006) is a biological process in which an amino group is removed from a nucleotide base within DNA, with the canonical example being the conversion of cytosine to uracil. This seemingly simple chemical modification has profound biological consequences: it can alter the coding potential of the genome, trigger DNA repair, and, when deliberately targeted by enzymes, generate immune diversity. The process is executed by a family of cytidine deaminases that includes activation-induced cytidine deaminase (AID) and the APOBEC proteins, which act on single-stranded DNA substrates. Because deamination can both diversify and damage DNA, it sits at the crossroads of immunity, mutagenesis, and cancer. Researchers study DNA deamination to understand antibody diversification, antiviral restriction, and the mutational signatures that drive tumor evolution. The availability of precise CRISPR-based models now allows causal interrogation of deaminase function in these contexts.
DNA deamination At A Glance
| GO ID | GO:0045006 |
|---|---|
| GO term | DNA deamination |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Removal of an amino group from a DNA nucleotide base, e.g., cytosine to uracil |
| Key enzymes | AID (AICDA) and APOBEC family cytidine deaminases |
| Biological context | Adaptive immunity, innate antiviral defense, and mutagenesis |
| Substrate | Single-stranded DNA exposed during transcription or replication |
What Is GO:0045006?
According to the Gene Ontology, DNA deamination (GO:0045006) is the removal of an amino group from a nucleotide base in DNA, for example the deamination of cytosine to produce uracil. This definition captures both enzymatic and spontaneous chemical events that alter the informational content of DNA.
Why Is DNA deamination Important in Cell Biology?
DNA deamination is fundamentally important because it provides a regulated mechanism for generating genetic diversity in the immune system while also posing a constant threat to genome integrity. AID-initiated deamination of cytosine to uracil in immunoglobulin genes is essential for somatic hypermutation and class-switch recombination, processes that underpin antibody affinity maturation. APOBEC enzymes can restrict viral replication by deaminating viral DNA, but their off-target activity on host DNA contributes to mutational signatures in cancer. Spontaneous deamination also occurs, with strand bias that may influence mutation patterns. Understanding DNA deamination is therefore critical for immunology, virology, and oncology research.
• Required for somatic hypermutation and class-switch recombination in B cells.
• Provides innate antiviral defense by deaminating viral genomes.
• Contributes to mutational signatures in multiple cancers.
• APOBEC3A-driven deamination is causally linked to hepatocellular carcinoma in vivo.
• Spontaneous cytosine deamination shows strand bias, affecting mutation landscapes.
• Offers a target for understanding and modulating immune diversity.
• Can be harnessed in base editing technologies for precise genome modification.
• Reveals DNA damage patterns detectable by single-molecule sequencing.
What Happens During DNA deamination?
Substrate recognition and single-stranded DNA exposure
In simple terms: The enzyme needs to catch DNA in a single-stranded state to do its job.
DNA deaminases such as AID and APOBEC enzymes act on single-stranded DNA (ssDNA) that is transiently exposed during transcription or replication. The enzymes must access the target cytosine within a preferred sequence context, and their activity is tightly linked to processes that unwind the DNA duplex.
Catalytic deamination of cytosine to uracil
In simple terms: The enzyme removes an amino group from cytosine, turning it into uracil.
The catalytic core of AID/APOBEC enzymes coordinates a zinc ion and performs hydrolytic deamination of cytosine, converting it to uracil in DNA. This creates a U:G mismatch that is recognized by cellular repair pathways.
Processing of uracil lesions by DNA repair
In simple terms: The uracil is either repaired or used to introduce mutations.
Uracil in DNA is processed by base excision repair (BER) or mismatch repair (MMR), and the choice of pathway influences whether the outcome is error-free repair or mutagenesis. In B cells, error-prone processing of AID-induced uracil lesions generates somatic hypermutation.
Strand bias and spontaneous deamination
In simple terms: Deamination happens more often on one DNA strand than the other.
Spontaneous deamination of cytosine to uracil is biased to the non-transcribed DNA strand in yeast, likely because the transcribed strand is more accessible to repair. This strand asymmetry can shape mutation patterns across genomes.
Detection and sequencing of deamination events
In simple terms: New sequencing methods can see where deamination has occurred.
Single-molecule sequencing approaches can reveal DNA mismatch and damage patterns, including those arising from deamination, providing a high-resolution view of these lesions. Such methods help link deamination to mutational signatures in disease.
Key Genes Involved in GO:0045006 DNA deamination
The following genes encode the principal enzymes and associated factors that mediate or respond to DNA deamination.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AICDA (AID) | Initiates cytosine deamination in immunoglobulin genes for antibody diversification | Core regulator of somatic hypermutation and class-switch recombination |
| APOBEC1 | Deaminates cytosine in RNA and DNA; founding member of APOBEC family | Model for understanding APOBEC substrate specificity |
| APOBEC3A | Deaminates cytosine in ssDNA; restricts viruses and can mutate host DNA | Causally linked to hepatocellular carcinoma in vivo |
| APOBEC3B | DNA deaminase implicated in antiviral defense and cancer mutagenesis | Associated with mutational signatures in breast and other cancers |
| APOBEC3G | Deaminates viral DNA to restrict HIV-1 and other retroviruses | Key model for innate antiviral deamination |
| APOBEC3F | DNA deaminase with antiviral activity | Studied for its role in retroviral restriction |
| APOBEC3H | DNA deaminase with polymorphic activity | Relevant to host-virus interactions |
| UNG | Uracil-DNA glycosylase; removes uracil from DNA | Central to processing AID-induced lesions |
| MBD4 | Methyl-CpG binding domain protein 4; glycosylase involved in repair of deaminated bases | Links deamination to mismatch repair |
| TDG | Thymine DNA glycosylase; excises mismatched bases | Participates in BER of deaminated bases |
| MSH2 | Mismatch repair protein; recognizes U:G mismatches | Required for error-prone processing in SHM |
| MSH6 | Mismatch repair protein; partners with MSH2 | Modulates mutation outcome at deaminated sites |
| POLH | Error-prone polymerase; introduces mutations at A:T pairs during SHM | Key effector of mutagenic processing |
| REV1 | Translesion synthesis polymerase; involved in SHM | Contributes to mutation spectrum |
| RPA | Single-stranded DNA binding protein; facilitates deaminase access | Supports substrate presentation |
| SRSF1 | Splicing factor that can modulate AID activity | Potential regulatory node |
| CTNNBL1 | Interacts with AID and influences its function | Modulates deaminase targeting |
| SEC23B | Coat protein complex component; may affect AID secretion | Emerging role in deaminase regulation |
How Is DNA deamination Regulated?
DNA deamination is regulated at multiple levels. AID expression is induced in activated B cells and its activity is controlled by phosphorylation, subcellular localization, and interaction partners. APOBEC enzymes are regulated by interferon signaling, alternative splicing, and protein stability. The availability of single-stranded DNA substrate, dictated by transcription and replication, also constrains deaminase activity. Mismatch repair and base excision repair pathways determine the downstream consequences of deamination, effectively regulating whether mutations are fixed or repaired.
DNA deamination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOBEC3A | Hepatocellular carcinoma | Knockout and overexpression in liver cancer cell lines |
| AICDA | Hyper-IgM syndrome and antibody deficiency | Point-mutation knock-in in B cell lines |
| APOBEC3G | HIV-1 restriction and viral escape | Knockout in T cell lines and viral infection assays |
| UNG | Defective repair of deaminated bases | Knockout in cell lines with deaminase induction |
| MBD4 | Mismatch repair deficiency and cancer predisposition | Knockout in colorectal cancer models |
Cancer mutagenesis and APOBEC-driven tumors
APOBEC-mediated DNA deamination contributes to mutational signatures in many cancers, and APOBEC3A-driven deamination is required for hepatocellular carcinoma development in vivo. These findings link deamination directly to tumor initiation and progression.
Immunodeficiency and antibody diversification defects
Loss of AID function impairs somatic hypermutation and class-switch recombination, leading to hyper-IgM syndrome and defective humoral immunity. This highlights the essential role of DNA deamination in adaptive immunity.
Viral restriction and host-pathogen conflict
APOBEC3 enzymes deaminate viral DNA, restricting retroviruses such as HIV-1, and viruses have evolved countermeasures. This ongoing conflict shapes viral evolution and host susceptibility.
Genome instability and mutational load
Spontaneous and enzymatic deamination generate uracil lesions that, if unrepaired, can cause C-to-T transitions and genome instability. Single-molecule sequencing reveals these damage patterns.
From DNA deamination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of APOBEC3A reduce tumor formation? | APOBEC3A knockout in hepatocellular carcinoma cell lines |
| Does a specific AID mutation abolish deaminase activity? | Point-mutation knock-in of AICDA in B cell lines |
| Can a tagged deaminase be tracked in live cells? | Knock-in of fluorescent tag at the endogenous locus |
| Does overexpression of APOBEC3B increase mutation load? | Overexpression in non-tumorigenic cell lines |
| Is UNG required for processing AID-induced uracil? | UNG knockout with AID induction |
| Does strand bias depend on transcription? | Knockout of transcription-coupled repair factors in yeast |
How to Study the DNA deamination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-molecule sequencing | DNA mismatch and damage patterns | Mapping deamination lesions genome-wide |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement for deaminase in cancer |
| Base editing | Precise C-to-T or A-to-G changes | Modeling deamination-related mutations |
| In vitro deaminase assay | Enzymatic activity on ssDNA | Substrate specificity studies |
| Whole-genome sequencing | Mutational signatures | Linking APOBEC activity to cancer |
| RNA-seq | Gene expression changes | Identifying interferon-induced APOBECs |
| Yeast genetics | Strand bias of spontaneous deamination | Studying transcription-coupled repair |
Sequencing-based detection of deamination
Single-molecule sequencing can directly reveal DNA mismatch and damage patterns, including uracil lesions from deamination. This approach provides base-resolution maps of deamination events.
Genetic knockout and point-mutation models
CRISPR-Cas9 knockout of deaminase genes or point mutations in catalytic residues allows causal testing of deamination in immune and cancer phenotypes. Base editors, which themselves exploit deamination chemistry, can be used to introduce precise mutations.
Biochemical assays for deaminase activity
In vitro deamination assays using ssDNA substrates and recombinant AID/APOBEC enzymes measure catalytic activity and substrate specificity. These assays help dissect mechanism and inhibition.
Transcriptomic and mutational signature analysis
RNA-seq and whole-genome sequencing can identify expression changes and mutational signatures associated with deaminase activity. Such analyses link deamination to disease subtypes.
How CRISPR Can Be Used to Study GO:0045006 DNA deamination
Knockout
CRISPR knockout of AID or APOBEC genes is used to test their requirement in immune diversification and cancer cell survival. For example, APOBEC3A knockout reduces hepatocellular carcinoma formation in vivo.
Point Mutation
Point mutations in the catalytic domain of deaminases can be introduced to separate enzymatic activity from other functions. Such models help define the contribution of deamination to phenotype.
Knock-in
Knock-in of epitope or fluorescent tags at endogenous deaminase loci enables real-time tracking and interaction studies. This approach preserves native regulation.
Overexpression
Overexpression of APOBEC enzymes in cell lines is used to model mutational signatures and viral restriction. It can reveal gain-of-function effects in cancer.
How EDITGENE Supports DNA deamination Research
Researchers studying DNA deamination-related genes often need to determine whether a candidate gene is causally involved in immune diversification, viral restriction, or cancer mutagenesis. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for DNA deamination research.
Frequently Asked Questions About DNA deamination
What is DNA deamination (GO:0045006)?
DNA deamination is the removal of an amino group from a DNA nucleotide base, such as the conversion of cytosine to uracil.
What genes are involved in DNA deamination?
Key genes include AICDA (AID) and APOBEC family members such as APOBEC3A, APOBEC3B, and APOBEC3G.
How does DNA deamination contribute to immunity?
AID-induced deamination of cytosine in immunoglobulin genes initiates somatic hypermutation and class-switch recombination, which are essential for antibody diversity.
Is DNA deamination mutagenic?
Yes, deamination creates uracil lesions that can lead to C-to-T transitions if unrepaired, and APOBEC enzymes contribute to cancer mutational signatures.
What is the role of APOBEC3A in cancer?
APOBEC3A-driven DNA deamination is required for hepatocellular carcinoma development in vivo.
How is DNA deamination detected in the lab?
Single-molecule sequencing can reveal DNA mismatch and damage patterns from deamination, and biochemical assays measure deaminase activity.
Does DNA deamination occur on both DNA strands?
Spontaneous cytosine deamination is biased to the non-transcribed DNA strand in yeast, indicating strand asymmetry.
What diseases are linked to defective DNA deamination?
Defects in AID cause hyper-IgM syndrome, while APOBEC dysregulation is linked to cancer and viral restriction.
Can CRISPR be used to study DNA deamination?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of deaminase function.
What is the relationship between DNA deamination and base editing?
CRISPR base editors exploit deamination chemistry to perform precise C-to-T or A-to-G changes in DNA.
Conclusion
DNA deamination (GO:0045006) is a fundamental biological process that bridges immunity, mutagenesis, and disease. Its study has revealed essential roles for AID and APOBEC enzymes in antibody diversification, antiviral defense, and cancer. With advanced CRISPR models and sequencing technologies, researchers can now dissect the mechanisms and consequences of deamination with unprecedented precision. EDITGENE provides the tools to accelerate this research.
References
- 1. Lapinaite A et al.. 2020. DNA capture by a CRISPR-Cas9-guided adenine base editor.. Science 369(6503):566-571 PMID: 32732424
- 2. Petersen-Mahrt S. 2005. DNA deamination in immunity.. Immunol Rev 203:80-97 PMID: 15661023
- 3. Neuberger MS et al.. 2003. Immunity through DNA deamination.. Trends Biochem Sci 28(6):305-12 PMID: 12826402
- 4. Pecori R et al.. 2022. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination.. Nat Rev Genet 23(8):505-518 PMID: 35256818
- 5. Liu MH et al.. 2024. DNA mismatch and damage patterns revealed by single-molecule sequencing.. Nature 630(8017):752-761 PMID: 38867045
- 6. Conticello SG et al.. 2007. DNA deamination in immunity: AID in the context of its APOBEC relatives.. Adv Immunol 94:37-73 PMID: 17560271
- 7. Naumann JA et al.. 2023. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo.. Int J Mol Sci 24(11) PMID: 37298259
- 8. Williams JD et al.. 2023. Spontaneous deamination of cytosine to uracil is biased to the non-transcribed DNA strand in yeast.. DNA Repair (Amst) 126:103489 PMID: 37018983
